Baker Tilly Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Baker Tilly Wealth Management's AMGN Position: Q2 2026 in Review
Baker Tilly Wealth Management reduced its Amgen (AMGN) stake by 0.13% in Q2 2026, selling an estimated $685 and leaving 1,484 shares worth $537K. The position accounts for 0.11% of the portfolio, ranked #158.
Baker Tilly Wealth Management first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.6M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Baker Tilly Wealth Management held 1,484 shares of Amgen worth $537K as of Q2 2026.
- Baker Tilly Wealth Management sold 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.11% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #158 holding.
- Baker Tilly Wealth Management first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- Baker Tilly Wealth Management's Amgen position peaked at $1.6M in Q4 2022.
- 1,338 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.